Yasuhiko Hirabayashi

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.

Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.

Journal: Fukushima journal of medical science

Published: March 29, 2023

Tocilizumab can efficiently prevent bone destruction in patients with recent-onset rheumatoid arthritis.

Tocilizumab can efficiently prevent bone destruction in patients with recent-onset rheumatoid arthritis.

Journal: Modern rheumatology

Published: December 04, 2020

Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.

Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.

Journal: Modern rheumatology

Published: April 29, 2020

Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.

Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.

Journal: Modern rheumatology

Published: March 03, 2016

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.

Journal: Arthritis care & research

Published: August 21, 2014

Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.

Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.

Journal: The Tohoku journal of experimental medicine

Published: June 06, 2014

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.

Journal: Modern rheumatology

Published: November 23, 2013

Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.

Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.

Journal: Modern rheumatology

Published: November 23, 2013

Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.

Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.

Journal: Modern rheumatology

Published: November 21, 2013

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.

The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.

Journal: Clinical rheumatology

Published: March 29, 2012

Discussion meeting on treatment of rheumatoid arthritis with biologics and their side effects

Discussion meeting on treatment of rheumatoid arthritis with biologics and their side effects

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Published: December 20, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026